• The specific situation of the patient. Unless otherwise provided for by national regulations,
off-label use of medication should be limited to situations where it is in the patient's interest …

Hypertension (HTN) is a major modifiable risk factor for cardiovascular disease (CVD)
morbidity and mortality. The left ventricle (LV) is a primary target for HTN end-organ damage …

Kardiomiopatie definiuje się jako strukturalne oraz funkcjonalne nieprawidłowości mięśnia
komór, które nie wynikają z niedokrwienia na skutek choroby wieńcowej czy …

Ventricular arrhythmias are an important cause of morbidity and mortality and come in a
variety of forms, from single premature ventricular complexes to sustained ventricular …

Aortic stenosis is characterized both by progressive valve narrowing and the left ventricular
remodeling response that ensues. The only effective treatment is aortic valve replacement …

Cardiac fibrosis is central to the pathology of heart failure, particularly heart failure with
preserved ejection fraction (HF p EF). Irrespective of the underlying profibrotic condition (eg …

Cardiovascular magnetic resonance provides insights into myocardial structure and function
noninvasively, with high diagnostic accuracy and without ionizing radiation. Myocardial …

Diffuse interstitial or replacement myocardial fibrosis is a common feature of a broad variety
of cardiomyopathies. Myocardial fibrosis leads to impaired cardiac diastolic and systolic …

Myocardial fibrosis is an important part of cardiac remodeling that leads to heart failure and
death. Myocardial fibrosis results from increased myofibroblast activity and excessive …

Hypertension remains a major contributor to the global burden of disease. The
measurement of blood pressure continues to have pitfalls related to both physiological …